NephroSant Features QSant, the first urine test for kidney transplant rejection, at Biotech Showcase Digital 2022

/PRNewswire/ -- NephroSant, Inc. a biotechnology company dedicated to accelerating the diagnosis of early kidney damage in native and transplanted kidneys,...

Related Keywords

Minnie Sarwal ,Brian Talbert ,Gina Ford ,Centers For Medicare Medicaid Services ,Nephrosant Early Access Program ,Nephrosant Inc ,Business Development ,Biotech Showcase ,Chronic Kidney Disease ,Medicaid Services ,Local Coverage Determination ,Science Translational Medicine ,Early Access Program ,Vice President ,Chief Business Development ,Nephrosant ,